Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Unrecognized SBC cost by Year
Unrecognized SBC cost — Stock options (historical, $M) ($M)
Vertex Pharmaceuticals Unrecognized SBC cost: $2.20M in FY2022, down 88.5% from a year earlier. No newer figure appears in the documents we track.
Where the FY2022 figure comes from
Source: Form 10-K (filed 2023-02-10) ↗
Reported in Form 10-K Note (Stock-based Compensation).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Unrecognized SBC cost — Stock options (historical, $M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2022 | Dec 31, 2022 | 2.20 | -88.5% | Form 10-K (filed 2023-02-10) ↗ |
| FY2021 | Dec 31, 2021 | 19.1 | -69.4% | Form 10-K (filed 2022-02-09) ↗ |
| FY2020 | Dec 31, 2020 | 62.4 | -52.1% | Form 10-K (filed 2021-02-11) ↗ |
| FY2019 | Dec 31, 2019 | 130 | -16.3% | Form 10-K (filed 2020-02-13) ↗ |
| FY2018 | Dec 31, 2018 | 156 | +5.5% | Form 10-K (filed 2019-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 147 | -6.6% | Form 10-K (filed 2018-02-15) ↗ |
| FY2016 | Dec 31, 2016 | 158 | – | Form 10-K (filed 2017-02-23) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Unrecognized SBC cost ($M), annual FY2016–FY2022 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/sbc-unrec-opt
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.